PK/PD Study of YZJ-1139

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 7, 2019

Primary Completion Date

April 10, 2019

Study Completion Date

November 15, 2019

Conditions

Insomnia

Interventions

DRUG

YZJ-1139

DRUG

Placebo

Oral tablet

DRUG

Zolpidem

Oral tablet

Trial Locations (1)

Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors

lead

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

INDUSTRY

NCT06685341 - PK/PD Study of YZJ-1139 | Biotech Hunter | Biotech Hunter